BSE Live
Sep 29, 16:01Prev. Close
875.70
Open Price
875.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 25, 15:57Prev. Close
689.35
Open Price
691.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
672.25 (249)
Profit & Loss account of Novartis India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 356.26 | 334.04 | 369.11 | 387.57 | 365.61 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 356.26 | 334.04 | 369.11 | 387.57 | 365.61 | |
Total Operating Revenues | 356.27 | 335.07 | 378.74 | 399.87 | 381.35 | |
Other Income | 41.96 | 61.68 | 58.11 | 33.19 | 33.09 | |
Total Revenue | 398.23 | 396.75 | 436.85 | 433.06 | 414.44 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 199.07 | 189.98 | 199.34 | 187.26 | 135.88 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 3.75 | 9.86 | 2.35 | -9.13 | 10.74 | |
Employee Benefit Expenses | 18.72 | 22.96 | 35.64 | 101.89 | 108.51 | |
Finance Costs | 0.77 | 1.49 | 1.75 | 4.83 | 7.68 | |
Depreciation And Amortisation Expenses | 2.19 | 2.61 | 6.06 | 9.65 | 12.16 | |
Other Expenses | 43.48 | 46.84 | 75.96 | 92.74 | 99.43 | |
Total Expenses | 267.81 | 273.91 | 321.47 | 387.24 | 374.40 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 130.42 | 122.84 | 115.38 | 45.82 | 40.04 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | -49.64 | 0.00 | |
Profit/Loss Before Tax | 130.42 | 122.84 | 115.38 | -3.82 | 40.04 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 29.96 | 37.63 | 1.68 | 0.00 | 17.89 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -0.44 | 0.02 | 10.34 | 0.34 | -3.48 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | -0.44 | 4.73 | |
Total Tax Expenses | 29.52 | 37.65 | 12.02 | -0.10 | 19.14 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 100.90 | 85.19 | 103.36 | -3.72 | 20.90 | |
Profit/Loss From Continuing Operations | 100.90 | 85.19 | 103.36 | -3.72 | 20.90 | |
Profit/Loss For The Period | 100.90 | 85.19 | 103.36 | -3.72 | 20.90 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 | |
Diluted EPS (Rs.) | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 61.73 | 117.28 | 24.69 | 24.69 | 24.69 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 500.00 | 500.00 | 950.00 | 200.00 | 200.00 |
30.07.2025
Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y
29.01.2025
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
28.10.2024
Novartis India Standalone September 2024 Net Sales at Rs 87.10 crore, up 10.59% Y-o-Y
29.07.2024
Novartis India Standalone June 2024 Net Sales at Rs 92.29 crore, up 1.87% Y-o-Y